Institutional Ownership Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS). We have compiled data on the 308 institutions that hold shares in the stock, with a total of 115 Million shares, which have been reported (via 13F filing form) to have a value of $3.01 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
15,566,969
shares
|
$408 Million
0.08% of portfolio
|
Q3 2024
Reduced 5.01%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
11,890,843
shares
|
$311 Million
14.88% of portfolio
|
Q3 2024
Added 2.44%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
11,111,111
shares
|
$291 Million
4.82% of portfolio
|
Q1 2023
Added 4.58%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
9,815,575
shares
|
$257 Million
0.01% of portfolio
|
Q3 2024
Added 0.06%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,795,272
shares
|
$152 Million
0.01% of portfolio
|
Q2 2024
Added 5.47%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
4,400,654
shares
|
$115 Million
4.68% of portfolio
|
Q3 2024
Added 76.03%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,040,861
shares
|
$106 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.55%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
3,884,730
shares
|
$102 Million
0.01% of portfolio
|
Q3 2024
Added 22.26%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
3,389,785
shares
|
$88.7 Million
0.01% of portfolio
|
Q3 2024
Added 59.98%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2024 Q3 2024 |
3,125,183
shares
|
$81.8 Million
2.55% of portfolio
|
Q3 2024
Added 410.82%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,006,980
shares
|
$78.7 Million
20.95% of portfolio
|
Q3 2024
Added 4.38%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,985,272
shares
|
$78.2 Million
0.05% of portfolio
|
Q3 2024
Reduced 26.26%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
2,167,224
shares
|
$56.7 Million
3.12% of portfolio
|
Q3 2024
New holding
|
|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
2,144,415
shares
|
$56.1 Million
0.13% of portfolio
|
Q3 2024
Added 191.87%
|
|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
1,821,115
shares
|
$47.7 Million
0.03% of portfolio
|
Q3 2024
Reduced 49.29%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,810,526
shares
|
$47.4 Million
0.0% of portfolio
|
Q3 2024
Added 1.26%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
1,747,510
shares
|
$45.7 Million
0.02% of portfolio
|
Q3 2024
Reduced 5.13%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,726,000
shares
|
$45.2 Million
2.64% of portfolio
|
Q4 2023
Added 9.52%
|
|
|
Fiera Capital Corp
Montreal, A8 |
Nov 01, 2024 Q3 2024 |
1,354,469
shares
|
$35.5 Million
0.12% of portfolio
|
Q3 2024
Reduced 3.33%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,270,400
shares
|
$33.3 Million
0.86% of portfolio
|
Q3 2024
Reduced 2.49%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
1,082,000
shares
|
$28.3 Million
0.19% of portfolio
|
Q3 2024
Added 0.24%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
975,004
shares
|
$25.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.02%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
956,362
shares
|
$25 Million
0.01% of portfolio
|
Q3 2024
Added 0.98%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
928,624
shares
|
$24.3 Million
0.1% of portfolio
|
Q2 2023
Added 106.34%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
860,294
shares
|
$22.5 Million
0.01% of portfolio
|
Q3 2024
Added 9.74%
|